Shareholders' Equity (Tables)

12 Months Ended

Feb. 01, 2020

Equity [Abstract]

Number of Awards Authorized and Available for Grant Under 2001 and 2018 Plan

The following table sets forth the number of awards authorized and available for grant under the 2018 Plan at February 1, 2020 (shares in thousands):

	2018 Plan
Total awards authorized	4,100
Awards available for grant	2,920

Summary of Stock Option Information

The following table sets forth the summary of stock option information for the year ended February 1, 2020 (shares in thousands):

	Number of Shares	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value
Outstanding on February 2, 2019	2,034	$	5.81
Canceled or forfeited	(595)	6.27
Outstanding on February 1, 2020	1,439	$	5.62	4.21 years	$	—
Exercisable stock options at February 1, 2020	796	$	5.60	3.46 years	$	—

Summary of Non-Vested Stock Activity

The following table sets forth non-vested stock activity for the year ended February 1, 2020 (shares in thousands):

	Restricted Stock Awards				Restricted Stock Units				Performance Share Awards
	Shares		Weighted- Average Grant Date Fair Value		Shares		Weighted- Average Grant Date Fair Value		Shares		Weighted- Average Grant Date Fair Value
Non-vested on February 2, 2019	800		$	2.84	1,355		$	1.81	484		$	0.80
Vested	(116)		5.32		(418)		2		—		—
Canceled or forfeited	(99)		3.03		(175)		1.85		(484)		0.80
Non-vested on February 1, 2020	585		$	2.30	762		$	1.80	—		$	—
Total unrecognized compensation cost	$	247			$	442			$	—
Weighted-average expected life remaining	0.9 years				0.6 years				N/A

Pre-Tax Share-Based Compensation Expense

The following table sets forth the share-based compensation expense for the years ended February 1, 2020 and February 2, 2019 (in thousands):

	Year Ended February 1, 2020		Year Ended February 2, 2019
Cost of merchandise sold	$	481	$	1,276
Selling, general and administrative expenses	1,047		2,833
Total share-based compensation expense	$	1,528	$	4,109